Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System.
Michele FusaroliArndis SimonsenStephanie A BorrieDaniel M LowAlberto ParolaEmanuel RaschiElisabetta PoluzziRiccardo FusaroliPublished in: Journal of speech, language, and hearing research : JSLHR (2023)
https://doi.org/10.23641/asha.23721345.